A TikTok video explaining how mRNA COVID-19 vaccines work against the virus has gone viral. Viewers have lauded the video, which features COVID-19 as a villain with fork hands and the immune system as a scientist, for its education content. A video showing how mRNA vaccine works goes viral Actor Vick Krishna @hotvickkrishna plays a
Anglo-Swedish drugmaker AstraZeneca (NASDAQ:AZN) has sold its entire 7.7% equity stake in COVID-19 vaccine producer Moderna Inc. (NASDAQ:MRNA) for over $1 billion. The company sold the entire stake over the course of 2020, cashing in the meteoric rise of the US biotechnology firm’s shares following its success in the production of a COVID-19 vaccine candidate.
Walmart Inc (NYSE:WMT) is spearheading the vaccination drive against the havoc-causing COVID-19. The nation’s largest retailer has expanded the number of locations where the vaccines are available in Georgia, from 10 to 60. Retail Chain Vaccination Drive Similarly, the number of Sam’s Club locations offering the vaccine has increased from two to six, including 14
The European Medicines Agency has approved AstraZeneca Plc (NASDAQ:AZN) and the University of Oxford’s COVID-19 vaccine. The move comes following a row that AstraZeneca might be breaking its commitment to deliver the vaccine to the EU. AstraZeneca Vaccine approved in the EU On Friday, the EMA said that after assessing the vaccines’ effectiveness and safety,
Anheuser-Busch is the latest high profile brand to deal this year’s Super Bowl a big blow. For the first time in more than 25 years, the beverage giant will not air any ads as has always been the norm during the major sporting event. Instead, the company says it will donate all the money to
The U.S real estate sector has shrugged off the shocks triggered by the COVID-19 pandemic to cap one of the finest runs amid a challenging macro environment. Contrary to expectations, the pandemic has fueled activities in the sector as health concernstriggered the digitization of the home buying process. Pandemic Triggered Home Buying As remote-working took
AstraZeneca plc. (NASDAQ: AZN) has quashed concerns about the efficacy of its experimental COVID-19 vaccine. In recent weeks, there have been growing concerns about the vaccine’s ability to combat the deadly virus, especially the new strain causing havoc in Europe. The AstraZeneca vaccine had initially shown an average of 70% effectiveness, but that level is
It promises to be a busy week, with tremendous investment opportunities, on a closer look of the big developments slated for the week ahead. The Coronavirus vaccine’s emergency authorization should be the central theme; a week after the U.K approved the distribution of the much-needed vaccine. COVID-19 Vaccine Authorization The U.S Foods and Drugs Administration
Default on Chinese bonds is on the rise, all but arousing concerns among bond investors. Demand for such bonds has taken a significant hit in the wake of the U.S government hitting a number of state firms with sanctions. November saw the lowest number of issued bonds in seven months by Chinese companies, down by
Equities are poised to start the last month of the year on a high, on the heels of a record month. All the major indices registered impressive gains in November amid a wave of uncertainty owing to the U.S election and the ever-growing COVID-19 risk. November Rally The Dow posted its biggest monthly gain since
The Dow Jones Industrial Average and the S&P 500 came under pressure on the last day of trading in November. The Dow was down by about 0.8% as the S&P 500 slipped by 0.5% before recouping some of the losses. The slip came amid an improving COVID-19 vaccine situation. Moderna Inc. (NASDAQ: MRNA) had initially
U.S stocks finished higher on Monday after a choppy start to the week. Hopes a COVID-19 vaccine continued to boost investor’s sentiments on stocks with sensitive sectors such as energy and industrials racing higher Stocks Rally Likewise, stock futures climbed in overnight trading on Monday following a strong session at the start of the week.
Hopes of a faster economic recovery are the catalyst behind U.S treasury yields’ recent spike. The rebound hopes have been affirmed by Moderna unveiling a COVID-19 vaccine that is 95% effective. Even as U.S Treasury yields show signs of edging higher, Chinese Bonds remain under pressure. Treasury Yield Rally The Yield on the 10-year Treasury
Confirmation of a COVID-19 vaccine that is 90% effective continues to elicit a mixed reaction in the capital market. As stocks battered by the COVID-19 pandemic raced higher, others came down, tumbling on huge volume. Gold is one of the commodities that felt the full wrath as investors bet on a return to normalcy following
President Donald Trump Administration is already planning for the future as drug maker’s inch closer to gaining regulatory approval for coronavirus vaccines. The administration has confirmed that senior citizens in long-term healthcare facilities will get a vaccine free of charge once made available. Clinical trials The announcement comes at a time when most drug-makers working